Principal Howard Birnbaum Discusses Post Marketing Requirements for Opioid Drug Products
Event:Public Meeting on the Post Marketing Requirements for the Class-Wide Extended-Release/Long-Acting Opioid Analgesics
Date:May 20, 2014
Host:U.S. Food and Drug Administration
Location:Silver Spring, MD
Dr. Birnbaum is an invited discussant at a U.S. Food and Drug Administration meeting on the design and conduct of the Post Marketing Requirements (PMR) for Extended Release/Long Acting (ER/LA) opioid drug products to further assess the serious risks of misuse, abuse, addiction, overdose, and death associated with their long-term use.
View additional information
Associated Experts & Staff